Benzinga | Feb 25, 2021 09:16AM EST

HC Wainwright & Co. Maintains Buy on ESSA Pharma, Lowers Price Target to $32

HC Wainwright & Co. analyst Joseph Pantginis maintains ESSA Pharma (NASDAQ:EPIX) with a Buy and lowers the price target from $36 to $32.